Onxeo SA:企業のM&A・事業提携・投資動向

◆英語タイトル:Onxeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2109
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Onxeo SA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Onxeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Onxeo SA since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Onxeo SA’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Onxeo SA. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Onxeo SA’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Onxeo SA and its subsidiaries since 2007.
- Information about key financial and legal advisors for Onxeo SA’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Onxeo SA’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 12
Partnership – Overview 12
Partnership – Deal reports 13
CAPITAL RAISING 59
Capital Raising – Overview 59
Capital Raising – Deal reports 60
PRIVATE EQUITY & OWNERSHIP 69
Private Equity and Ownership – Deal reports 69
APPENDIX 70
Contact Us 70
About MarketLine Financial Deals Database 70
Deal Definition and Methodology 72
About MarketLine 79

List of Tables
Table 1: Onxeo SA M&A volume and value trend (2014-YTD2018)
Table 2: Onxeo SA M&A activity by geography (2014-YTD2018)
Table 3: Onxeo SA partnership volume and value trend (2014-YTD2018)
Table 4: Onxeo SA partnership trend by key deal type (2014-YTD2018)
Table 5: Onxeo SA capital raising volume and value trend (2014-YTD2018)
Table 6: Onxeo SA capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Onxeo SA M&A volume and value trend (2014-YTD2018)
Figure 2: Onxeo SA M&A activity by geography (2014-YTD2018)
Figure 3: Onxeo SA partnership volume and value trend (2014-YTD2018)
Figure 4: Onxeo SA partnership trend by key deal type (2014-YTD2018)
Figure 5: Onxeo SA capital raising volume and value trend (2014-YTD2018)
Figure 6: Onxeo SA capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Onxeo SA:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Statnett SF-エネルギー分野:企業M&A・提携分析
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • ADInstruments Pty Ltd:企業の戦略的SWOT分析
    ADInstruments Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Azul SA (AZUL4):企業の財務・戦略的SWOT分析
    Azul SA (AZUL4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • DFDS A/S:企業の戦略・SWOT・財務情報
    DFDS A/S - Strategy, SWOT and Corporate Finance Report Summary DFDS A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Ind-Swift Ltd (INDSWFTLTD):企業の財務・戦略的SWOT分析
    Summary Ind-Swift Ltd (Ind-Swift), is a pharmaceutical company that develops, manufactures and markets finished goods dosage, active pharmaceutical ingredients and herbal products. The company offers products such as dispersible tablets, sustained release tablets, mouth dissolving tablets, chewable …
  • Delek US Holdings, Inc.:企業のM&A・事業提携・投資動向
    Delek US Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delek US Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • FBN Bank (UK) Ltd:企業の戦略・SWOT・財務情報
    FBN Bank (UK) Ltd - Strategy, SWOT and Corporate Finance Report Summary FBN Bank (UK) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Southern Co (SO):石油・ガス:M&Aディール及び事業提携情報
    Summary Southern Co is a gas and electric utility holding company. It generates, distributes, markets and trades electricity and distributes gas. It uses a variety of sources for electricity generation including coal, oil and gas, nuclear and hydro. The company also distributes natural gas through t …
  • Arbor Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Arbor Pharmaceuticals LLC (Arbor) is a healthcare products provider that develops prescription products for the hospital, cardiovascular and pediatric segments. The company offers licensing, manufacturing, development and commercialization of late-stage prescription products. It also offers …
  • University of Pennsylvania:企業のM&A・事業提携・投資動向
    University of Pennsylvania - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Pennsylvania Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Bob Evans Farms, Inc.:企業の戦略・SWOT・財務情報
    Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bob Evans Farms, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Boehringer Ingelheim GmbH:戦略・SWOT・企業財務分析
    Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report Summary Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Uranium Energy Corp:企業の戦略・SWOT・財務情報
    Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • American Shared Hospital Services (AMS):企業の財務・戦略的SWOT分析
    Summary American Shared Hospital Services (ASHS) is a distributor of medical equipment to hospitals and medical centers. The company also offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning and design, s …
  • Aramark (ARMK):企業の財務・戦略的SWOT分析
    Aramark (ARMK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • French National Institute of Health and Medical Research-医療機器分野:企業M&A・提携分析
    Summary French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immu …
  • OMRON Corporation:企業の戦略・SWOT・財務分析
    OMRON Corporation - Strategy, SWOT and Corporate Finance Report Summary OMRON Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • OncoStem Diagnostics Pvt. Ltd:企業の製品パイプライン分析2018
    Summary OncoStem Diagnostics Pvt Ltd (OncoStem) is a provider of clinical trial solutions. The company develops multimaker prognostic and predictive testing enabling detecting and treating patients affected with cancer. It develops various tests in identifying patterns of repetition in cancer. OncoS …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆